Orasis Pharmaceuticals Ltd.
6 clinical trials · Sponsor
◉ Watch Orasis Pharmaceuticals Ltd.
| Record | Firm | Date |
|---|---|---|
| An Evaluation of the Safety of CSF-1 in Presbyopic Subjects (NCT05393895) | Orasis Pharmaceuticals Ltd. | 2022-04-22 |
| An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2) (NCT04599972) | Orasis Pharmaceuticals Ltd. | 2020-10-26 |
| An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1) (NCT04599933) | Orasis Pharmaceuticals Ltd. | 2020-10-18 |
| A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia (NCT03885011) | Orasis Pharmaceuticals Ltd. | 2019-02-26 |
| Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects (NCT02965664) | Orasis Pharmaceuticals Ltd. | 2016-12-01 |
| Safety, Tolerability, and Efficacy of PresbiDrops (CSF-1), a Topical Ophthalmic Drug for Presbyopia (NCT02745223) | Orasis Pharmaceuticals Ltd. | 2016-07-01 |
Track Orasis Pharmaceuticals Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.